Диссертация (1141206), страница 25
Текст из файла (страница 25)
Kang J.Z., Meng C.X., Zhang L. et al. The census of the 185pharmaceutists with the knowledge of emergency contraceptive pill in Shanghai //Chinese Journal of Obstetrics and Gynecology. — 2007. — Vol. 42.– P.138–139.164. Kajantie E., Raivio T., Janne O.A. et al. Circulating glucocorticoidbioactivity in the preterm newborn after antenatal betamethasone treatment // J.Clin.
Endocr. Metab. — 2004. — Vol. 89. — P.3999–4003.165. Kapoor A., Dunn E., Kostaki A. et al. Fetal programming ofhypothalamopituitary–adrenal function: prenatal stress and glucocorticoids // Am.J. Physiol. — 2006. — Vol.572. — P.31–44.166. Kapoor A., Petropoulos S., Matthews S.G. Fetal programming ofhypothalamic–pituitary–adrenal (HPA) axis function and behavior by syntheticglucocorticoids // Brain Res. Rev.
— 2008. — Vol. 57.– P.586–595.167. Kelly R.W. Pregnancy maintenance and parturition: the role ofprostaglandin in manipulating the immune and inflammatory response // EndocrineRev. — 1994. — Vol. 15. — P. 684–706.168. Kempna P., Fluck C.E. Adrenal gland development and defects // BestPract. Res.
Clin. Endocrinol. Metab. — 2008. — Vol.22. — P.77–93.169. Krupp P., Monka C. Bromocriptine in pregnancy: safety aspects //Klin. Wochenschr. — 1987. — Vol. 65(17). — P.823–827.145170. Kupperman H. Progesterone and related steroids in the managementof abortion // In Progesterone (A. Barnes, Ed.), 1961. — P. 105–117.171. Lalitkumar P.G., Lalitkumar S., Meng C.X. et al. Mifepristone, butnot levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrialthree–dimensional cell culture model // Hum.
Reprod. — 2007. — Vol. 22. —P.3031–3037.172. Lee B.H., Stoll B.J., Mcdonald S.A., Higgins R.D. Adverse neonataloutcomes associated with antenatal dexamethasone versus antenatal betamethasone// Pediatrics. — 2006. — Vol. 117. — P.1503–1510.173. LeeB.H.,StollB.J.,McdonaldS.A.,HigginsR.D.Neurodevelopmental outcomes of extremely low birth weight infants exposedprenatally to dexamethasone versus betamethasone // Pediatrics. — 2008. — Vol.121.
— P.289–296.174. Leitao V.M., Moroni R.M., Seko L.M. et al. Cabergoline for theprevention of ovarian hyperstimulation syndrome: systematic review and meta–analysis of randomized controlled trials // Fertil. Steril. — 2014. — Vol.101(3). —P.664–675.175.
Leitich H., Kaider A. Fetal fibronectin — how useful is it in theprediction of preterm birth? // Brit. J. Obstet. Gynaec. — 2003. — Vol. 110(Suppl. 20). — P.66–70.176. Liu J., Feng Z.C., Li J., Wang Q. Antenatal dexamethasone has noadverse effects on child physical and cognitive development: a long–term cohortfollow–up investigation // J. Matern. Fetal Neonatal Med. — 2012. — Vol.25(11). — P.2369–2371.177. Liu L., Li A., Matthews S.G.
Maternal glucocorticoid treatmentprograms HPA regulation in adult offspring: sex–specific effects // Am. J. Physiol.Endocrinol. Metab. — 2001. — Vol. 280. — P.29–39.178. Lockwood C.J, Krikun G., Schatz F. Decidual cell–expressed tissuefactor maintains hemostasis in human endometrium // Ann N Y Acad Sci. — 2001.— Vol.943. — P.77–88.146179.
Lu G.F. Analyze the results of mental development of children in1076 cases // Shanghai Journal of Preventive Medicine. — 2008. — Vol. 20. —P.447–448.180. Maccarrone M., Valensise H., Bari M. et al. Progesterone up–regulates anandamide hydrolase in human lymphocytes: role of cytokines andTriplications for fertility // J. Immunol. — 2001. — Vol.
166 (12). — P. 7183–7189.181. Macnab A.J., Zouves C. Hypospadias after assisted reproductionincorporating in vitro fertilization and gamete intrafallopian transfer // Fertil. Steril.— 1991. — Vol.56. — P. 918–922.182. Maier W.E., Herman J.R. Pharmacology and toxicology of ethinylestradiol and norethindrone acetate in experimental animals // Regul. Toxicol.Pharmacol. — 2001. — Vol.34. — P.53–61.183.
Manson J.M., Carr M.C. Molecular epidemiology of hypospadias:review of genetic and environmental risk factors // Birth Defects Res. Part A Clin.Mol. Teratol. — 2003. — Vol.67. — P.825–836.184. Marions L., Cekan S.Z., Bygdeman M., Gemzell–Danielsson K.Effect of emergency contraception with levonorgestrel or mifepristone on ovarianfunction // Contraception. — 2004.
— Vol. 69. — P.373–377.185. Matthews S.Antenatal glucocorticoids and the developing brain:mechanisms and action // Semin. Neonatol. — 2001. — Vol.6. — P.309–317.186. Matthews S. Antenatal glucocorticoids and programming of thedeveloping CNS // Pediatr Res. — 2000. — Vol. 47. — P.291–300.187. Meeker J.D. Exposure to environmental endocrine disruptors andchild development // Arch. Pediatr. Adolesc.
Med. — 2012. — Vol.166 (10).–P.952–958.188. Michaelis J., Michaelis H., Gluck E., Koller S. Prospective study ofsuspected associations between certain drugs administered during early pregnancyand congenital malformations // Teratology. — 1983. — Vol.27. — P. 57–64.147189. Miller N.M., Williamson C., Fisk N.M., Glover V. Infant cortisolresponse after prolonged antenatal prednisolone treatment // Brit. J. Obstet.Gynaec. — 2004. — Vol.
111.– P.1471–1474.190. Mullis P.E., Tonella P. Regulation of fetal growth: consequencesand impact of being born small // Best Pract. Res. Clin. Endocrinol. Metab. —2008. –Vol.22 (1). — P.173–190.191. Murphy V.E., Clifton V.L. Alterations in human placental 11beta–hydroxysteroid dehydrogenase type 1 and 2 with gestational age and labour //Placenta. — 2003. — Vol. 24. — P.739–744.192. Newnham J.P., Jobe A.H.
Should we be prescribing repeated coursesof antenatal corticosteroids? // Semin. Fetal Neonatal. Med. — 2009. — Vol.14.— P.157–163.193. Nishimura H., Tanimura T. Clinical aspects of the teratogenicity ofdrugs // Experta Medica. — 1976. –Vol.12. — P. 150.194. Noorlander C.W., De Graan P.N., Middeldorp J.
et al. Ontogeny ofhippocampal corticosteroid receptors: effects of antenatal glucocorticoids in humanand mouse // J. Comp. Neurol. — 2006. — Vol. 499.– P.924–932.195. Norwitz E.R., Caughey A.B. Progesterone supplementation and theprevention of preterm birth // Rev.
Obstet. Gynecol. — 2011. — Vol. 4. — P.60–72.196. Nykanen P., Raivio T., Heinonen K. et al. Circulating glucocorticoidbioactivity and serum cortisol concentration in premature infants: The influence ofexogenous glucocorticoids and clinical factors // Eur. J. Endocrinol. — 2007. —Vol. 156. — P.577–583.197. Oates–Whitehead R., Haas D., Carrier J. Progestogen for preventingmiscarriage (Cochrane Review). — The Cochrane Library John Wiley & Sons,Ltd, Chichester, 2004.198.
Ogasawara M., Aoki K. Successful uterine steroid therapy in a casewith a history of ten miscarriage // Am. J. Reprod. Immunol. — 2000. — Vol.44, № 4. — P. 253–255.148199. Okada A., Ohta Y., Buchanan D. et al. Effect of estrogens onontogenetic expression of progesterone receptor in the fetal female rat reproductivetract // Mol. Cell Endocrinol. — 2002. — Vol.195. — P.55–64.200. Pakkila F., Mannisto T., Pouta A. et al. The impact of gestationalthyroid hormone concentrations on ADHD symptoms of the child // J.
Clin.Endocrinol. Metab. — 2014. — Vol.99 (1). — P.1–8.201. Palmer J.R., Wise L.A., Hatch E.E., et al. Prenatal diethylstilbestrolexposure and risk of breast cancer // Cancer Epidemiol. Biomarkers Prev. — 2006.— Vol.15. — P.1509–1514.202. Palomba S., Marotta R., Di Cello A. et al. Pervasive developmentaldisorders in children of hyperandrogenic women with polycystic ovary syndrome:a longitudinal case–control study // Clin. Endocrinol. (Oxf). — 2012. — Vol.77(6). — P.898–904.203. Patel B., Elguero S., Thakore S. et al.
Role of nuclear progesteronereceptor isoforms in uterine pathophysiology // Hum Reprod Update. — 2015. —Vol. 21 (2). — P.155–173.204. Peltoniemi O.M., Kari M.A., Hallman M. Repeated antenatalcorticosteroid treatment: a systematic review and meta–analysis // Acta obstetriciaet gynecologica Scandinavica. — 2011. — Vol.
90. — P.719–727.205. Phillips D.I. Programming of the stress response: a fundamentalmechanism underlying the longterm effects of the fetal environment? // J. Intern.Med. — 2007.– Vol.261. — P.453–460.206. Regan D.O., Welberg L., Holmes M., Seckl J. Glucocorticoidprogramming of pituitary–adrenal Function: mechanisms and physiologicalconsequences // Semin. Neonatol. — 2001.
— Vol. 6. — P. 319–329.207. Resseguie L.J., Hick J.F., Bruen J.A. et al. Congenital malformationsamong offspring exposed in utero to progestins, Olmsted County, Minnesota,1936–1974 // Fertil. Steril. — 1985. — Vol.43. — P. 514–519.149208. Reynolds R.M., Walker B.R., Syddall H.E. et al., Altered CortisolSecretion in Adult Men with Low Birth Weight and Cardiovascular Risk Factors //J. Clin. Endocrinol. Metah.
— 2001. — Vol. 86. — Р. 245–250.209. Ritzen M. Prenatal dexametasone treatment of fetuses at risk forcongenital adrenal hyperplasia: benefits and concerns // Semin1. Neonatol. —2001. — Vol.6. — P.357–362.210. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetallung maturation for women at risk of preterm birth // Cochrane Database Syst. Rev.— 2006.
— Vol.3. –CD004454.211. Rock J.A., Wentz A.C., Cole K.A. et al. Fetal malformationsfollowing progesterone therapy during pregnancy: a preliminary report // Fertil.Steril. — 1985. — Vol.44. — P.17–19.212. Roghair R.D., Lamb F.S., Miller F.J. et al. Early gestationdexamethasone programs enhanced postnatal ovine coronary artery vascularreactivity // Am. J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
